Correlation between breadth of memory HIV-specific cytotoxic T cells, viral load and disease progression in HIV infection

AIDS

Volumn 16, Issue 18, 2002, Pages 2399-2407

  Chouquet, Cécile ^a   Autran, Brigitte ^b   Gomard, Elisabeth ^a   Bouley, Jean Marc ^b   Calvez, Vincent ^a   Katlama, Christine ^b   Costagliola, Dominique ^a   Rivière, Yves ^c,d   Pasquier, S ^a   Corre, B ^a   Janvier, G ^a   Porrot, F ^a   Hadida, F ^a   Samri, A ^a   Bonduelle, O ^a   Durali, M ^a   Richard, M ^a   Agut, H ^a   Delaugerre, C ^a   Simon, A ^a  

^a INSERM   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c INSTITUT PASTEUR   (France)

^d CNRS   (France)

Author keywords

Chronic HIV infection; Disease progression; Memory HIV specific CTL; Viral load

Indexed keywords

ANTIRETROVIRUS AGENT; GAG PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; NEF PROTEIN; POL PROTEIN; REV PROTEIN; TRANSACTIVATOR PROTEIN; VIF PROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN;

ADULT; ARTICLE; CHROMIUM 51 RELEASE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; EFFECTOR CELL; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEMORY CELL; MULTIVARIATE ANALYSIS; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; VIRUS LOAD; VIRUS REPLICATION;

ADULT; CHRONIC DISEASE; COHORT STUDIES; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOLOGIC MEMORY; MALE; PROSPECTIVE STUDIES; T-LYMPHOCYTES, CYTOTOXIC; VIRAL LOAD;

EID: 0037032880     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200212060-00004     Document Type: Article

References (44)

1. Reimann KA, Tenner-Racz K, Racz P, Montefiori DC, Yasutomi Y, Lin W, et al. Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques. J Virol 1994, 68:2362-2370.
2. Yasutomi Y, Reimann KA, Lord CI, Miller MD, Letvin NL. Simian immunodeficiency virus-specific CD8+ lymphocyte response in acutely infected rhesus monkeys. J Virol 1993, 67:1707-1711.
3. Koup RA, Safrit JT, Cao Y, Andrews CA, McLeod G, Borkowsky W, et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 1994, 68:4650-4655.
4. Borrow P, Lewicki H, Hahn BH, Shaw GM, Oldstone MB, Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 1994, 68:6103-6110.
5. Musey L, Hughes J, Schacker T, Shea T, Corey L, McElrath MJ. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type-1 infection. N Engl J Med 1997, 337:1267-1274.
6. Schmitz JE, Kuroda ML, Santra S, Sasseville VG, Simon MA, Lifton MA., et al. Control of viremia in simian immunodeficiency virus infection by CD8+lymphocytes. Science 1999, 283:857-860.
7. Jin X, Bauer DE, Tuttleton SE, Lewin S, Gettie A, Kostrikis L, et al. Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. J Exp Med 1999, 189:991-998.
8. Rinaldo C, Huang XL, Fan ZF, Ding M, Beltz L, Logar A, et al. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors. J Virol 1995, 69:5838-5842.
9. Ferbas J, Kaplan AH, Hausner MA, et al. Virus burden in long-term survivors of human immunodeficiency virus (HIV) infection is a determinant of anti-HIV CD8+ lymphocyte activity. J Infect Dis 1995, 172:329-339.
10. Klein MR, Van Baalen CA, Holwerda AM, Kerkhof Garde SR, Bende RJ, Keet IP, et al. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: A longitudinal analysis of rapid progressors and long-term asymptomatics. J Exp Med 1995, 181:1365-1372.
11. Grenough TC, Brettler DB, Somasundaran M, Panicalli DL, Sullivan JL. Human immunodeficiency virus type-1 specific cytotoxic-T-lymphocytes (CTL), virus load, and CD4 T cell loss: Evidence supporting a role for CTL in vivo. J Infect Dis 1997, 176:118-125.
12. Harrer T, Hatter E, Kalams SA, et al. Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection. AIDS Res Hum Retroviruses 1996, 12:585-592.
13. Ogg GS, Jin X, Bonhoeffer S, Dunbar PR, Nowak MA, Monard S, et al. Quantitation of HIV-1 specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 1998, 278:2103-2106.
14. Pontesilli O, Klein MR, Kerkhof-Garde SR, Pakker NG, de Wolf F, Schuitemaker H, et al. Longitudinal analysis of human immunodeficiency virus type 1-specific cytotoxic-T-lymphocyte responses: A predominant Gag-specific response is associated with non-progressive infection. J Inf Dis 1998, 178:1008-1018.
15. Rivière Y, McChesney MB, Porrot F, Feuillie V, Mollereau M, Chamaret S, et al. Gag-specific cytotoxic responses to HIV type 1 are associated with a decreased risk of progression to AIDS-related complex or AIDS. AIDS Res Hum Retroviruses 1995, 11:903-907.
16. Van Baalen CA, Pontesilli O, Huisman RC, Geretti AM, Klein MR, de Wolf F, et al. Human immunodeficiency virus type 1 Rev- and Tat-specific cytotxic T lymphocyte frequencies inversely correlate with rapid progression to AIDS. J Gen Virol 1997, 78:1913-1918.
17. Rivière Y, Tanneau-Salvadori F, Regnault A, Lopez O, Sansonetti P, Guy B, et al. Human immunodeficiency virus-specific cytotoxic responses of seropositive individuals: Distinct types of effector cells mediate killing of targets expressing gag and env proteins. J Virol 1989, 63:2270-2277.
18. Chenciner N, Michel F, Dadaglio G, Langlade-Demoyen P, Hoffenbach A, Leroux A, et al. Multiple subsets of HIV-specific cytotoxic T lymphocytes in humans and in mice. Eur J Immunol 1989, 19:1537-1544.
19. Haas G, Plikat U, Debre P, Luchiari M, Katalina C, Dudoit Y, et al. Dynamics of viral variants in HIV-1 Nef and specific cytotoxic T lymphocytes in vivo. J Immunol 1996, 157:4212-4221.
20. Wolinsky SM, Korber BT, Neumann AU, Daniels M, Kunstman KJ Whetsell AJ, et al. Adapative evolution of human immunodeficiency virus-type 1 during the natural course of infection. Science 1996, 272:537-542.
21. Price DA, Goulder PJ, Klenerman P, Sewell AK, Easterbrook PJ, Troop M, et al. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc Natl Acad Sci, USA 1997, 94:1890-1895.
22. Borrow P, Lewicki H, Wei X, Horwitz MS, Peffer N, Meyers H, et al. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nature Med 1997, 3:205-211.
23. Pantaleo G, Soudeyns H, Demarest JF, Vaccareza M, Graziosi Paolucci S, Daucher MB, et al. Accumulation of human immunodeficiency virus-specific cytotoxic T lymphocytes away from the predominant site of virus replication during primary infection. Eur J Immunol 1997, 27:3166-3173.
24. Goulder PJ, Phillips RE, Colbert RA, McAdam S, Ogg G, Nowak MA, et al. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nature Med 1997, 3:212-217.
25. Dalod M, Dupuis M, Deschemin JC, Sicard D, Salmon D, Delfraissy J-F, et al. Broad, intense anti-human immunoeficiency virus (HIV) ex vivo CD8(+) responses in HIV type 1-infected patients: Comparison with anti-Epstein-Barr virus responses and changes during antiretroviral therapy. J Virol 1999, 73:7108-7116.
26. Goulder PJ, Altfeld MA, Rosenberg ES, Nguyen T, Tang Y, Eldridge RL, et al. Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection. J Exp Med 2001, 193:181-194.
27. Champagne P, Ogg GS, King AS, Knaberhans C, Ellefsen K, Nobile M, et al. Skewed maturation of memory HIV-specific CD8 lymphocytes. Nature 2001, 410:108-110.
28. Pantaleo G, Koenig S, Baseler M, Lane HC, Fauci AS. Defective clonogenic potential of CD8+ T lymphocytes in patients with AIDS. J Immunol 1990, 144:1696-1705.
29. Centers for Disease Control and prevention. Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1993, 41:1-19.
30. Kievits T, van Gemen B, van Strijp D, Schukkink R, Dircks M, Adriaanse H, et al. NASBA isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection. J Virol Methods 1991, 35:273-286.
31. Lamhamedi-Cherradi S, Culmann-Penciolelli, B, Guy B, Duong Ly T, Goujard C, Guillet JG, et al. Different patterns of HIV-1 specific cytotoxic T-lymphocyte activity after primary infection. AIDS 1995, 9:421-426.
32. Buseyne F, Blanche S, Schmitt D, Griscelli C, Rivière Y. Detection of HIV-specific mediated cytotoxicity in peripheral blood from infected children infected. J Immunol 1993, 150:3569-3581.
33. Nixon DF, Townsend ARM, Elvin JG, Rizza CR, Galwey J, McMichael AJ. HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides. Nature 1988, 336:484-489.
34. Fleiss JL. Statistical Methods for Rates and Proportions, 2nd Edn. New York: Wiley, 1981.
35. Laird N, Ware J. Random-effects models for longitudinal data. Biometrics 1982, 38:963-974.
36. Diggle PJ, Liang KY, Zeger SLÒ Analysis of Longitudinal Data. New York: Oxford University Press Inc., 1994.
37. st Edn. Cary, NC: SAS Institute Inc., 1988.
38. Buseyne F, Chaix M, Fleury B, Manigard O, Burgard M, Blanche S, et al. Cross-clade Specific Cytotoxic T Lymphocytes in HIV-1 Infected Children. Virology 1998, 250:316-324.
39. Kalams SA, Johnson RP, Trocha AK, Dynan MJ, Ngo HS, D'Aquila RT, et al. Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire. J Exp Med 1994, 179:1261-1271.
40. Buseyne F, Burgard M, Teglas JP, Bui E, Rouzioux C, et al. Early HIV-specific cytotoxic T lymphocytes and disease progression in children born to HIV-infected mothers. AIDS Res Hum Retroviruses 1998, 14:1435-1444.
41. Gea-Banacloche JC, Migueles SA, Martino L, Shupert WL, McNeil AC, Sabbaghian MS, et al. Maintenance of large numbers of virus-specific CD8+ T cells in HIV-infected progressors and long-term nonprogressors. J Immunol 2000, 165:1082-1092.
42. Murali-Krishna K, Altman JD, Suresh M, Sourdive D, Zajac A, Ahmed R. In vivo dynamics of anti-viral CD8 T cell responses to different epitopes. An evaluation of bystander activation in primary and secondary responses to viral infection. Adv Exp Med Biol 1998, 452:123-142.
43. Gray CM, Lawrence J, Schapiro JM, Altman JD, Winters MA, Crompton M, et al. Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART). J Immunol 1999, 162:1780-1788.
44. Mollet L, Li TS, Samri A, Tournay C, Tubiana R, the RESTIM and COMET study groups, et al. Dynamics of HIV-specific CD8+ T lymphocytes with changes in viral load. The RESTIM and COMET Study Groups. J Immunol 2000, 165:1692-1704.